Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy

Triple-negative breast cancer (TNBC) typically has a worse outcome than other breast cancer subtypes, in part owing to a lack of approved therapeutic targets or prognostic markers. We have previously described an oncogenic pathway in basal-like TNBC cells, initiated by insulin-like growth factor bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Julovi, Sohel M., Martin, Janet L., Baxter, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874320/
https://www.ncbi.nlm.nih.gov/pubmed/29623068
http://dx.doi.org/10.3389/fendo.2018.00120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874320/
https://www.ncbi.nlm.nih.gov/pubmed/29623068
http://dx.doi.org/10.3389/fendo.2018.00120

Ejemplares similares